Viara Research
Laboratory supply · Viara group
Viara Wellness
Viara Research laboratory reference material: Tesamorelin 10 mg, NAD+ 500 mg and KLOW 10 mg lyophilised vials, purity at or above 99 percent by HPLC, certificate of analysis per lot. For research use only. Not for human or veterinary consumption. Supplied to institutions against a stated research use.
Viara Research NAD+ laboratory reference material, 10 mg lyophilised vial, purity at or above 99 percent by HPLC. For research use only. Not for human or veterinary consumption. Supplied to institutions against a stated research use.
Catalog

Don’t take our word. Take the lot data.

Every fill is batch-coded and tied to a certificate of analysis you can request by lot number — identity and purity for the vial in front of you, not a representative run.

Format
10 mg lyophilised
Purity
≥ 99% by HPLC
Paperwork
COA per lot, on request
Supplied to
Institutions only

Orders go against a stated research use. Not to individuals, and not to clinics sourcing material for patients.

7 compounds
Swipe for the range 1 / 7
Viara Research Retatrutide vial, 10 mg lyophilised, labelled for research use only

Retatrutide

Unapproved · Not compoundable

Investigational triple agonist at the GIP, GLP-1 and glucagon receptors. Approved nowhere; supplied on enquiry only.

$115 per 10 mg vial
Format
10 mg lyophilised
Purity
≥ 99% (HPLC)
Note
Unapproved investigational agent
Request COA →
Viara Research BPC-157 vial, 5 mg lyophilised, labelled for research use only

BPC-157

Off Cat. 2 · PCAC 8–6–1

Pentadecapeptide matching a fragment of a protein found in gastric juice.

$58 per 5 mg vial
Format
5 mg lyophilised
Purity
≥ 99% (HPLC)
Request COA →
Viara Research TB-500 vial, 10 mg lyophilised, labelled for research use only

TB-500

Category 2 · FDA-identified risk

Synthetic fragment corresponding to the actin-binding region of thymosin β4.

$92 per 10 mg vial
Format
10 mg lyophilised
Purity
≥ 99% (HPLC)
Note
Category 2 — not compoundable
Request COA →
Viara Research BPC-157 / TB-500 vial, 5 mg / 5 mg lyophilised, labelled for research use only

BPC-157 / TB-500

Blend · Status by component

Two-component blend: the pentadecapeptide BPC-157 alongside TB-500.

$105 per 10 mg vial
Format
5 mg / 5 mg lyophilised
Purity
≥ 99% (HPLC)
Composition
Stated on COA
Request COA →
Viara Research CJC-1295 w/ DAC + Ipamorelin vial, 5 mg / 5 mg lyophilised, labelled for research use only

CJC-1295 w/ DAC + Ipamorelin

Blend · Contains Category 2

Two-component blend pairing the GRF(1–29) analogue with the pentapeptide ipamorelin.

$110 per 10 mg vial
Format
5 mg / 5 mg lyophilised
Purity
≥ 99% (HPLC)
Composition
Stated on COA
Request COA →
Viara Research Tesamorelin vial, 10 mg lyophilised, labelled for research use only

Tesamorelin

Approved analogue · EGRIFTA

Forty-four residue analogue of growth hormone-releasing hormone, acylated at the N-terminus.

$119 per 10 mg vial
Format
10 mg lyophilised
Purity
≥ 99% (HPLC)
Note
Approved form exists
Request COA →
Viara Research MOTS-c vial, 10 mg lyophilised, labelled for research use only

MOTS-c

Off Cat. 2 · PCAC 7–5–2

Sixteen residues, encoded in the mitochondrial genome rather than the nuclear one.

$76 per 10 mg vial
Format
10 mg lyophilised
Purity
≥ 99% (HPLC)
Request COA →
Primary structure

Every peptide here is a sequence.

Order of residues is what a peptide is. Pick a compound and its chain builds, coloured by the biochemical class of each residue — the same key used on the fingerprint under every product above.

Primary structure  
Hydrophobic
Polar
Basic
Acidic
Gly / Pro
Undisclosed
Regulatory

Where each compound actually stands.

Two things moved this year and most of our category has not updated its copy. Removal from Category 2 is not permission to compound, and an advisory vote is not a rule. Both matter if you are planning around availability.

CompoundApril 2026July 2026 — PCACCompoundable today
RetatrutideNot applicableNot applicableNo — unapproved drug
BPC-157Off Category 2Recommended, 8–6–1No — rulemaking pending
TB-500Category 2Not reviewedNo — Category 2
BPC-157 / TB-500BPC-157 off Category 2; TB-500 in Category 2BPC-157 recommended, 8–6–1No — TB-500 in Category 2
CJC-1295 + IpamorelinCJC-1295 in Category 2; ipamorelin off Category 2Not reviewedNo — CJC-1295 in Category 2
TesamorelinNot in this groupNot reviewedApproved form exists — EGRIFTA
MOTS-cOff Category 2Recommended, 7–5–2No — rulemaking pending
Eligibility

Who we can supply, and who we cannot.

Who this is for

  • Academic and institutional laboratories
  • Commercial R&D and contract research organisations
  • Analytical labs needing reference material
  • Buyers who can state an in-vitro or preclinical use

Who this is not for

  • Individuals buying for personal use
  • Clinics or prescribers sourcing patient material
  • Anyone intending human or veterinary administration
  • Resale into consumer channels
Documentation

What you get, and what to ask for.

Certificate of analysis

Requested, not enclosed. Certificates are not shipped with the vial — ask for one by lot number, before or after purchase, and we issue it for that lot. Identity, purity by HPLC and the analytical detail your records need, tied to the lot in front of you rather than a representative run.

Batch code and fill date

Printed at fill, so any vial traces back to its production run. If a lot is ever withdrawn you can tell in seconds whether you hold it.

Handling and storage

Lyophilised, shipped ambient, with reconstitution and storage guidance for laboratory conditions. Cold chain available on request for longer transit.

Enquiries

Tell us the institution and the use.

Orders are accepted from institutions and research organisations against a stated research use. Enquiries are screened before anything is quoted — institutional email, organisation type and a stated use are all conditions of supply. Once you clear, we confirm availability, lot and lead time, and send the certificate of analysis for the lot you are quoted.

Supply conditions. We can only accept enquiries from an institution or research organisation, sent from that organisation’s own email domain, against a stated in-vitro or preclinical use. We do not supply individuals for personal use, and we do not supply clinics or prescribers sourcing material for patients.

Your organisation’s own domain. Personal email accounts are not accepted.
A sentence or more. “Research” on its own is not a stated use, and we will come back to you for the detail before quoting.

Or email orders@viararesearch.com.